Alternating electric fields arrest cell proliferation in animal tumor models and human brain tumors.

Proceedings of the National Academy of Sciences, Volume 104, No. 24, June 12, 2007.

Read Article

NovoTTF-100A versus physician’s choice chemotherapy in recurrent glioblastoma: A randomised phase III trial of a novel treatment modality

European Journal of Cancer, Volume 48, No. 12, 2012.

Read Article

Delayed response and survival from NovoTTF-100A in recurrent GBM.

Medical Oncology, Volume 3, No. 338, January 2013.

Read Article

Response assessment of NovoTTF-100A vs best physician’s choice of chemotherapy in recurrent glioblastoma.

Cancer Medicine, Volume 3, No. 3, 2014.

Read Article

Characterization and management of dermatologic adverse events with the NovoTTF-100A system, a novel anti-mitotic electric field device for the treatment of recurrent glioblastoma.

Seminars in Oncology, Volume 41, S1 – S14, June, 2014.

Read Article

Post hoc analyses of intention-to-treat population in phase III comparison of NovoTTF-100A™ system versus best physician’s choice chemotherapy.

Seminars in Oncology, Volume 41, S25 – S34, October, 2014.

Read Article

Response patterns of recurrent glioblastomas treated With Tumor Treating Fields.

Seminars in Oncology, Volume 41, S14 – S24, October, 2014.

Read Article

Clinical practice experience with NovoTTF-100A™ system for glioblastoma: the Patient Registry Dataset (PRiDe).

Seminars in Oncology, Volume 41, S4 – S13, October, 2014.

Read Article